世界のピモジド販売市場2021

QYResearchが発行した調査報告書(QYR21JN7844)
◆英語タイトル:Global Pimozide Sales Market Report 2021
◆商品コード:QYR21JN7844
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月5日
◆ページ数:131
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥532,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥798,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,064,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のピモジド市場について種類別(1Mg、2Mg、4Mg)、用途別(病院、ドラッグストア、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ピモジド市場の概要
・世界の主要地域別ピモジド市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のピモジド市場規模2016-2021:種類別(1Mg、2Mg、4Mg)
・世界のピモジド市場予測2012-2027:種類別(1Mg、2Mg、4Mg)
・世界のピモジド市場規模2016-2021:用途別(病院、ドラッグストア、その他)
・世界のピモジド市場予測2012-2027:用途別(病院、ドラッグストア、その他)
・ピモジドのアメリカ市場規模と予測2016-2021
・ピモジドのヨーロッパ市場規模と予測2016-2021
・ピモジドの中国市場規模と予測2016-2021
・ピモジドの日本市場規模と予測2016-2021
・ピモジドの東南アジア市場規模と予測2016-2021
・ピモジドのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Teva、Par Pharmaceutical、Johnson & Johnson、Eumedica、Pharmascience、Domina Pharmaceuticals、Aa Pharma)
・ピモジドの製造コスト分析
・販売チャネル、流通業者、顧客
・ピモジドの市場動向・機会・課題
・調査の結論
【レポートの概要】

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.

Market Analysis and Insights: Global Pimozide Market
The global Pimozide market was valued at US$ 12 in 2020 and will reach US$ 11 million by the end of 2027, growing at a CAGR of -0.9% during 2022-2027.

Global Pimozide Scope and Market Size
The global Pimozide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pimozide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
1Mg
2Mg
4Mg

Segment by Application
Hospitals
Drugstores
Others

The Pimozide market is analysed and market size information is provided by regions (countries). Segment by Application, the Pimozide market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma

【レポートの目次】

1 Pimozide Market Overview
1.1 Pimozide Product Scope
1.2 Pimozide Segment by Type
1.2.1 Global Pimozide Sales by Type (2016 & 2021 & 2027)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Pimozide Segment by Application
1.3.1 Global Pimozide Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Pimozide Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pimozide Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pimozide Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pimozide Price Trends (2016-2027)

2 Pimozide Estimates and Forecasts by Region
2.1 Global Pimozide Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pimozide Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pimozide Sales Market Share by Region (2016-2021)
2.2.2 Global Pimozide Revenue Market Share by Region (2016-2021)
2.3 Global Pimozide Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pimozide Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pimozide Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pimozide Estimates and Projections (2016-2027)
2.4.2 Europe Pimozide Estimates and Projections (2016-2027)
2.4.3 China Pimozide Estimates and Projections (2016-2027)
2.4.4 Japan Pimozide Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pimozide Estimates and Projections (2016-2027)
2.4.6 India Pimozide Estimates and Projections (2016-2027)
3 Global Pimozide Competition Landscape by Players
3.1 Global Top Pimozide Players by Sales (2016-2021)
3.2 Global Top Pimozide Players by Revenue (2016-2021)
3.3 Global Pimozide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pimozide as of 2020)
3.4 Global Pimozide Average Price by Company (2016-2021)
3.5 Manufacturers Pimozide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pimozide Market Size by Type
4.1 Global Pimozide Historic Market Review by Type (2016-2021)
4.1.1 Global Pimozide Sales Market Share by Type (2016-2021)
4.1.2 Global Pimozide Revenue Market Share by Type (2016-2021)
4.1.3 Global Pimozide Price by Type (2016-2021)
4.2 Global Pimozide Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pimozide Sales Forecast by Type (2022-2027)
4.2.2 Global Pimozide Revenue Forecast by Type (2022-2027)
4.2.3 Global Pimozide Price Forecast by Type (2022-2027)
5 Global Pimozide Market Size by Application
5.1 Global Pimozide Historic Market Review by Application (2016-2021)
5.1.1 Global Pimozide Sales Market Share by Application (2016-2021)
5.1.2 Global Pimozide Revenue Market Share by Application (2016-2021)
5.1.3 Global Pimozide Price by Application (2016-2021)
5.2 Global Pimozide Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pimozide Sales Forecast by Application (2022-2027)
5.2.2 Global Pimozide Revenue Forecast by Application (2022-2027)
5.2.3 Global Pimozide Price Forecast by Application (2022-2027)

6 North America Pimozide Market Facts & Figures
6.1 North America Pimozide Sales by Company
6.1.1 North America Pimozide Sales by Company (2016-2021)
6.1.2 North America Pimozide Revenue by Company (2016-2021)
6.2 North America Pimozide Sales Breakdown by Type
6.2.1 North America Pimozide Sales Breakdown by Type (2016-2021)
6.2.2 North America Pimozide Sales Breakdown by Type (2022-2027)
6.3 North America Pimozide Sales Breakdown by Application
6.3.1 North America Pimozide Sales Breakdown by Application (2016-2021)
6.3.2 North America Pimozide Sales Breakdown by Application (2022-2027)

7 Europe Pimozide Market Facts & Figures
7.1 Europe Pimozide Sales by Company
7.1.1 Europe Pimozide Sales by Company (2016-2021)
7.1.2 Europe Pimozide Revenue by Company (2016-2021)
7.2 Europe Pimozide Sales Breakdown by Type
7.2.1 Europe Pimozide Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pimozide Sales Breakdown by Type (2022-2027)
7.3 Europe Pimozide Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Pimozide Market Facts & Figures
8.1 China Pimozide Sales by Company
8.1.1 China Pimozide Sales by Company (2016-2021)
8.1.2 China Pimozide Revenue by Company (2016-2021)
8.2 China Pimozide Sales Breakdown by Type
8.2.1 China Pimozide Sales Breakdown by Type (2016-2021)
8.2.2 China Pimozide Sales Breakdown by Type (2022-2027)
8.3 China Pimozide Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)

9 Japan Pimozide Market Facts & Figures
9.1 Japan Pimozide Sales by Company
9.1.1 Japan Pimozide Sales by Company (2016-2021)
9.1.2 Japan Pimozide Revenue by Company (2016-2021)
9.2 Japan Pimozide Sales Breakdown by Type
9.2.1 Japan Pimozide Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pimozide Sales Breakdown by Type (2022-2027)
9.3 Japan Pimozide Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pimozide Market Facts & Figures
10.1 Southeast Asia Pimozide Sales by Company
10.1.1 Southeast Asia Pimozide Sales by Company (2016-2021)
10.1.2 Southeast Asia Pimozide Revenue by Company (2016-2021)
10.2 Southeast Asia Pimozide Sales Breakdown by Type
10.2.1 Southeast Asia Pimozide Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pimozide Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pimozide Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Pimozide Market Facts & Figures
11.1 India Pimozide Sales by Company
11.1.1 India Pimozide Sales by Company (2016-2021)
11.1.2 India Pimozide Revenue by Company (2016-2021)
11.2 India Pimozide Sales Breakdown by Type
11.2.1 India Pimozide Sales Breakdown by Type (2016-2021)
11.2.2 India Pimozide Sales Breakdown by Type (2022-2027)
11.3 India Pimozide Sales Breakdown by Application
11.3.1 India Pimozide Sales Breakdown by Application (2016-2021)
11.3.2 India Pimozide Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pimozide Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Pimozide Products Offered
12.1.5 Teva Recent Development
12.2 Par Pharmaceutical
12.2.1 Par Pharmaceutical Corporation Information
12.2.2 Par Pharmaceutical Business Overview
12.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Par Pharmaceutical Pimozide Products Offered
12.2.5 Par Pharmaceutical Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Pimozide Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Eumedica
12.4.1 Eumedica Corporation Information
12.4.2 Eumedica Business Overview
12.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eumedica Pimozide Products Offered
12.4.5 Eumedica Recent Development
12.5 Pharmascience
12.5.1 Pharmascience Corporation Information
12.5.2 Pharmascience Business Overview
12.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pharmascience Pimozide Products Offered
12.5.5 Pharmascience Recent Development
12.6 Domina Pharmaceuticals
12.6.1 Domina Pharmaceuticals Corporation Information
12.6.2 Domina Pharmaceuticals Business Overview
12.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Domina Pharmaceuticals Pimozide Products Offered
12.6.5 Domina Pharmaceuticals Recent Development
12.7 Aa Pharma
12.7.1 Aa Pharma Corporation Information
12.7.2 Aa Pharma Business Overview
12.7.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Aa Pharma Pimozide Products Offered
12.7.5 Aa Pharma Recent Development

13 Pimozide Manufacturing Cost Analysis
13.1 Pimozide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pimozide
13.4 Pimozide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pimozide Distributors List
14.3 Pimozide Customers

15 Market Dynamics
15.1 Pimozide Market Trends
15.2 Pimozide Drivers
15.3 Pimozide Market Challenges
15.4 Pimozide Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のピモジド販売市場2021(Global Pimozide Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。